These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23292818)

  • 1. Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis.
    Yaqub A; Chung L
    Curr Rheumatol Rep; 2013 Jan; 15(1):302. PubMed ID: 23292818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary arterial hypertension associated with systemic sclerosis.
    Mathai SC; Hassoun PM
    Expert Rev Respir Med; 2011 Apr; 5(2):267-79. PubMed ID: 21510736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature.
    Sundaram SM; Chung L
    Curr Rheumatol Rep; 2018 Feb; 20(2):10. PubMed ID: 29488016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of pulmonary arterial hypertension in systemic sclerosis patients with anti-centriole autoantibodies.
    Hamaguchi Y; Matsushita T; Hasegawa M; Ueda-Hayakawa I; Sato S; Takehara K; Fujimoto M
    Mod Rheumatol; 2015 Sep; 25(5):798-801. PubMed ID: 24252018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension in systemic sclerosis: different phenotypes.
    Launay D; Sobanski V; Hachulla E; Humbert M
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28954767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients.
    Giordano N; Montella A; Corallo C; Ruocco G; Chirico C; Palazzuoli A; Nuti R; Pecetti G
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S182-9. PubMed ID: 26339897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Hypertension in Scleroderma- Evaluation and Management.
    Chennakesavulu PV; Uppaluri S; Koyi J; Jhaveri S; Avanthika C; Sakhamuri LT; Ashokbhai PK; Singh P
    Dis Mon; 2023 Jul; 69(7):101468. PubMed ID: 36163292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.
    Vemulapalli S; Cohen L; Hsu V
    Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac complications of systemic sclerosis: recent progress in diagnosis.
    Boueiz A; Mathai SC; Hummers LK; Hassoun PM
    Curr Opin Rheumatol; 2010 Nov; 22(6):696-703. PubMed ID: 20657283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension phenotypes in patients with systemic sclerosis.
    Haque A; Kiely DG; Kovacs G; Thompson AAR; Condliffe R
    Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34407977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-age onset systemic sclerosis.
    Manno RL; Wigley FM; Gelber AC; Hummers LK
    J Rheumatol; 2011 Jul; 38(7):1317-25. PubMed ID: 21685299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on biomarker discovery and use in systemic sclerosis.
    Matsushita T; Takehara K
    Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review.
    Bazan IS; Mensah KA; Rudkovskaia AA; Adonteng-Boateng PK; Herzog EL; Buckley L; Fares WH
    Respir Med; 2018 Jan; 134():42-46. PubMed ID: 29413506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes.
    Brown Z; Proudman S; Morrisroe K; Stevens W; Hansen D; Nikpour M
    Semin Arthritis Rheum; 2021 Jun; 51(3):495-512. PubMed ID: 33857705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: From Bedside to Bench and Back Again.
    Bahi M; Li C; Wang G; Korman BD
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic scleroderma: Review and updated approach and case description to addressing pulmonary arterial hypertension and idiopathic pulmonary fibrosis: A dual challenge in treatment.
    Cueto-Robledo G; Tovar-Benitez D; Alfaro-Cruz A; Gonzalez-Hermosillo LM
    Curr Probl Cardiol; 2024 Apr; 49(4):102404. PubMed ID: 38232920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.
    Choi JH; Joo SJ; Kim J
    Int J Rheum Dis; 2016 Jan; 19(1):65-73. PubMed ID: 26820839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleroderma lung disease.
    Le Pavec J; Launay D; Mathai SC; Hassoun PM; Humbert M
    Clin Rev Allergy Immunol; 2011 Apr; 40(2):104-16. PubMed ID: 20063208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).
    Sobanski V; Launay D; Hachulla E; Humbert M
    Curr Rheumatol Rep; 2016 Feb; 18(2):10. PubMed ID: 26841964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis.
    Krikeerati T; Pussadhamma B; Mahakkanukrauh A; Suwannaroj S; Nanagara R; Foocharoen C
    Mod Rheumatol; 2021 May; 31(3):649-656. PubMed ID: 32924684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.